The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Capnocytophaga


High impact information on Capnocytophaga

  • Though capnine accumulates as such in the cells of some Capnocytophaga spp., most organisms of the Cytophaga-like genera contain, instead, sulfonolipids that are less polar than capnine [6].
  • The 34 beta-lactamase-positive strains were highly resistant to beta-lactams, but the intrinsic activities of clavulanate, tazobactam, and sulbactam against Capnocytophaga, even beta-lactamase producers, indicates that these beta-lactamase inhibitors could be used for empirical treatment of neutropenic patients with oral sources of infection [7].
  • A plasmid-encoded extended-spectrum TEM beta-lactamase with a pI of 5.5 was detected in a Capnocytophaga ochracea clinical isolate [8].
  • The bactericidal activities of purified defensins HNP-1 and HNP-2 were equal, and both of these activities were greater than HNP-3 activity against strains of Capnocytophaga sputigena and Capnocytophaga gingivalis [9].
  • In contrast, IgA1 proteases from Capnocytophaga ochracea and Capnocytophaga sputigena strains were apparently identical, while Capnocytophaga gingivalis had a protease that differed from those of the other Capnocytophaga species [10].

Chemical compound and disease context of Capnocytophaga


Biological context of Capnocytophaga


Anatomical context of Capnocytophaga


Gene context of Capnocytophaga


Analytical, diagnostic and therapeutic context of Capnocytophaga


  1. In vitro killing of oral Capnocytophaga by granule fractions of human neutrophils is associated with cathepsin G activity. Miyasaki, K.T., Bodeau, A.L. J. Clin. Invest. (1991) [Pubmed]
  2. Bactericidal activities of synthetic human leukocyte cathepsin G-derived antibiotic peptides and congeners against Actinobacillus actinomycetemcomitans and Capnocytophaga sputigena. Miyasaki, K.T., Bodeau, A.L., Pohl, J., Shafer, W.M. Antimicrob. Agents Chemother. (1993) [Pubmed]
  3. Antimicrobial susceptibilities of bacteria associated with periodontal disease. Sutter, V.L., Jones, M.J., Ghoneim, A.T. Antimicrob. Agents Chemother. (1983) [Pubmed]
  4. Bacteriology of experimental gingivitis in children. Moore, W.E., Holdeman, L.V., Smibert, R.M., Cato, E.P., Burmeister, J.A., Palcanis, K.G., Ranney, R.R. Infect. Immun. (1984) [Pubmed]
  5. Arylaminopeptidase activities of oral bacteria. Suido, H., Nakamura, M., Mashimo, P.A., Zambon, J.J., Genco, R.J. J. Dent. Res. (1986) [Pubmed]
  6. Sulfonolipids of gliding bacteria. Structure of the N-acylaminosulfonates. Godchaux, W., Leadbetter, E.R. J. Biol. Chem. (1984) [Pubmed]
  7. In vitro susceptibilities of Capnocytophaga isolates to beta-lactam antibiotics and beta-lactamase inhibitors. Jolivet-Gougeon, A., Buffet, A., Dupuy, C., Sixou, J.L., Bonnaure-Mallet, M., David, S., Cormier, M. Antimicrob. Agents Chemother. (2000) [Pubmed]
  8. Capnocytophaga ochracea: characterization of a plasmid-encoded extended-spectrum TEM-17 beta-lactamase in the phylum Flavobacter-bacteroides. Rosenau, A., Cattier, B., Gousset, N., Harriau, P., Philippon, A., Quentin, R. Antimicrob. Agents Chemother. (2000) [Pubmed]
  9. In vitro sensitivity of oral, gram-negative, facultative bacteria to the bactericidal activity of human neutrophil defensins. Miyasaki, K.T., Bodeau, A.L., Ganz, T., Selsted, M.E., Lehrer, R.I. Infect. Immun. (1990) [Pubmed]
  10. Enzymatic and antigenic characterization of immunoglobulin A1 proteases from Bacteroides and Capnocytophaga spp. Frandsen, E.V., Reinholdt, J., Kilian, M. Infect. Immun. (1987) [Pubmed]
  11. Carbon dioxide metabolism by Capnocytophaga ochracea: identification, characterization, and regulation of a phosphoenolpyruvate carboxykinase. Kapke, P.A., Brown, A.T., Lillich, T.T. Infect. Immun. (1980) [Pubmed]
  12. Phospholipid composition of gliding bacteria: oral isolates of Capnocytophaga compared with Sporocytophaga. Holt, S.C., Doundowlakis, J., Takacs, B.J. Infect. Immun. (1979) [Pubmed]
  13. In vitro killing of Actinobacillus actinomycetemcomitans and Capnocytophaga spp. by human neutrophil cathepsin G and elastase. Miyasaki, K.T., Bodeau, A.L. Infect. Immun. (1991) [Pubmed]
  14. Capnocytophaga haemolytica sp. nov. and Capnocytophaga granulosa sp. nov., from human dental plaque. Yamamoto, T., Kajiura, S., Hirai, Y., Watanabe, T. Int. J. Syst. Bacteriol. (1994) [Pubmed]
  15. Serological cross-reaction between Legionella spp. and Capnocytophaga ochracea by using latex agglutination test. Chen, S., Hicks, L., Yuen, M., Mitchell, D., Gilbert, G.L. J. Clin. Microbiol. (1994) [Pubmed]
  16. Hydrolysis of triclosan monophosphate by dental plaque and selected species of oral micro-organisms. Greenman, J., Nelson, D.G. J. Dent. Res. (1996) [Pubmed]
  17. Capnocytophaga gingivalis: effects of glucose concentration on growth and hydrolytic enzyme production. Spratt, D.A., Greenman, J., Schaffer, A.G. Microbiology (Reading, Engl.) (1996) [Pubmed]
  18. Human neutrophil azurocidin synergizes with leukocyte elastase and cathepsin G in the killing of Capnocytophaga sputigena. Miyasaki, K.T., Bodeau, A.L. Infect. Immun. (1992) [Pubmed]
  19. T lymphocyte disorder after Capnocytophaga ochracea endocarditis. Gormand, F., Etienne, J., Rigal, D., Bonnard, M., Fleurette, J., Beaune, J. Infection (1989) [Pubmed]
  20. B-cell mitogenicity and IL-1 beta production of lipopolysaccharides from various Capnocytophaga strains. Kim, S.J., Kato, T., Naito, Y., Hirai, K., Choi, J.I., Takazoe, I., Okuda, K. Bull. Tokyo Dent. Coll. (1994) [Pubmed]
  21. Cellulitis caused by Capnocytophaga cynodegmi associated with etanercept treatment in a patient with rheumatoid arthritis. Gerster, J.C., Dudler, J. Clin. Rheumatol. (2004) [Pubmed]
  22. Ammonia utilization by a proposed bacterial pathogen in human periodontal disease, Capnocytophaga ochracea. Grantham, W.C., Brown, A.T. Arch. Oral Biol. (1983) [Pubmed]
  23. Capnocytophaga canimorsus sp. nov. (formerly CDC group DF-2), a cause of septicemia following dog bite, and C. cynodegmi sp. nov., a cause of localized wound infection following dog bite. Brenner, D.J., Hollis, D.G., Fanning, G.R., Weaver, R.E. J. Clin. Microbiol. (1989) [Pubmed]
  24. New selective medium for the isolation of Neisseria gonorrhoeae. Evans, G.L., Kopyta, D.L., Crouse, K. J. Clin. Microbiol. (1989) [Pubmed]
  25. Differentiation of human Capnocytophaga species by multilocus enzyme electrophoretic analysis and serotyping of immunoglobulin A1 proteases. Frandsen, E.V., Wade, W.G. Microbiology (Reading, Engl.) (1996) [Pubmed]
  26. Inhibition of Prevotella and Capnocytophaga immunoglobulin A1 proteases by human serum. Frandsen, E.V., Kjeldsen, M., Kilian, M. Clin. Diagn. Lab. Immunol. (1997) [Pubmed]
  27. Serum antibodies and loss of periodontal bone in patients with rheumatoid arthritis. Tolo, K., Jorkjend, L. Journal of clinical periodontology. (1990) [Pubmed]
  28. Phospholipid analogue distribution in Capnocytophaga. Drucker, D.B., Wade, W.G., Abdi, M., Sayers, N.M., Boote, V., Law, D. Zentralbl. Bakteriol. (1999) [Pubmed]
WikiGenes - Universities